MARKET

SPPI

SPPI

Spectrum Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.280
-0.230
-6.55%
After Hours: 3.280 0 0.00% 16:37 03/03 EST
OPEN
3.470
PREV CLOSE
3.510
HIGH
3.560
LOW
3.260
VOLUME
3.21M
TURNOVER
--
52 WEEK HIGH
5.24
52 WEEK LOW
1.742
MARKET CAP
478.62M
P/E (TTM)
-2.3777
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
How Much Of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Do Institutions Own?
If you want to know who really controls Spectrum Pharmaceuticals, Inc. ( NASDAQ:SPPI ), then you'll have to look at the...
Simply Wall St. · 13h ago
Spectrum Pharma Highlights Presentation Of Twice-Daily Dosing Data For Poziotinib At European Society for Medical Oncology Targeted Anticancer Therapies Virtual Congress 2021 being held Mar. 1-2, 2021
Spectrum Pharmaceuticals (NASDAQ:SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today presented results from Cohort 3 and initial twice daily (BID) dosing safety and efficacy data
Benzinga · 1d ago
Spectrum Pharmaceuticals Presents Twice Daily Dosing Data for Poziotinib at the ESMO TAT Virtual Congress 2021
Spectrum Pharmaceuticals Presents Twice Daily Dosing Data for Poziotinib at the ESMO TAT Virtual Congress 2021
Business Wire · 1d ago
The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 1)
Benzinga · 1d ago
Global Non-Hodgkin Lymphoma Treatment Market 2020 Size, Share, Analysis, Demand, Growth Driver and Industry Segments by 2025
Mar 01, 2021 (CDN Newswire via Comtex) -- Global Non-Hodgkin Lymphoma Treatment Market Growth (Status and Outlook) 2020-2025 is the latest addition by...
CDN Newswire · 2d ago
Global Epigenetics Drugs and Diagnostic Technologies Professional Survey Market Outlook, Industry Analysis and Prospect 2021-2026
Mar 01, 2021 (Heraldkeepers) -- COMTEX_381924317/2582/2021-03-01T07:33:20 Is there a problem with this press release? Contact the source provider Comtex at...
Heraldkeepers · 2d ago
5 Penny Stock To Watch In March 2021 With Potential Biotech Catalysts
Feb 28, 2021 (Penny Stocks via COMTEX) -- Biotech Penny Stocks To Watch Right Now February closed out with a tumultuous week of trading in more than just...
Penny Stocks · 3d ago
The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and fast, with a skew of small and midcap companies releasing their quarterly results.
Benzinga · 4d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SPPI. Analyze the recent business situations of Spectrum Pharma through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SPPI stock price target is 10.40 with a high estimate of 15.00 and a low estimate of 5.00.
EPS
Institutional Holdings
Institutions: 279
Institutional Holdings: 105.15M
% Owned: 72.06%
Shares Outstanding: 145.92M
TypeInstitutionsShares
Increased
57
10.78M
New
44
-282.42K
Decreased
42
3.22M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-3.72%
Pharmaceuticals & Medical Research
-1.71%
Key Executives
Chairman/Independent Director
William Ashton
President/Chief Executive Officer/Director
Joseph Turgeon
Chief Financial Officer/Executive Vice President
Kurt Gustafson
Chief Operating Officer/Executive Vice President
Thomas Riga
Executive Vice President
Francois Lebel
Senior Vice President/Secretary
Keith McGahan
Senior Vice President
Lyndah Dreiling
Director
Nora Brennan
Independent Director
Seth Fischer
Independent Director
Jeffrey Vacirca
Independent Director
Dolatrai Vyas
Independent Director
Bernice Welles
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
12/10/2012
Dividend USD 0.15
12/18/2012
About SPPI
Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company operates through developing and commercializing oncology and hematology drug products segment. It focuses on developing ROLONTIS and POZIOTINIB. ROLONTIS is being investigated for the treatment of chemotherapy-induced neutropenia. POZIOTINIB is an oral pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR, HER) Family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations.

Webull offers kinds of Spectrum Pharmaceuticals, Inc. stock information, including NASDAQ:SPPI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SPPI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SPPI stock methods without spending real money on the virtual paper trading platform.